Improving Memory in Patients With Multiple Sclerosis
Status:
Withdrawn
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
People with multiple sclerosis (MS) suffer from cognitive and other brain problems. This
study will examine the effectiveness of the drug donepezil and of sugar water for enhancing
memory in individuals with MS. Donepezil (also known as Aricept) has been FDA approved for
improving memory and learning in individuals with Alzheimer's disease.
Phase:
Phase 3
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)